Viewing Study NCT00000803


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-03-05 @ 11:31 AM
Study NCT ID: NCT00000803
Status: COMPLETED
Last Update Posted: 2021-11-04
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module